S. Satoh

Novel series of 3-amino-N-(4-aryl-1,1-dioxothian-4-yl)butanamides as potent and selective dipeptidyl peptidase IV inhibitors.

H. Fujii, Mikiya Satoh, H. Kawai, 2012, Bioorganic & medicinal chemistry letters.

(3R)-3-amino-4-(2,4,5-trifluorophenyl)-N-{4-[6-(2-methoxyethoxy)benzothiazol-2-yl]tetrahydropyran-4-yl}butanamide as a potent dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.

H. Kozono, H. Fujii, Mikiya Satoh, 2008, Bioorganic & medicinal chemistry letters.

Late phase of long-term potentiation induced by co-application of N-methyl-d-aspartic acid and the antagonist of NR2B-containing N-methyl-d-aspartic acid receptors in rat hippocampus

M. Saji, N. Suzuki, M. Ogata, 2009, Neuroscience.